Don’t let the high cost of brand specialty asthma controller inhalers disrupt your treatment. We help eligible patients access Arnuity Ellipta (fluticasone furoate) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Arnuity Ellipta Prescription Assistance Program is a manufacturer-sponsored initiative that provides Arnuity at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for asthma patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, prescriber coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your asthma management, not paperwork.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$400.00 | Save ~$330/inhaler |
| CVS Pharmacy | ~$420.00 | Save ~$350/inhaler |
| Walmart | ~$340.00 | Save ~$270/inhaler |
| Costco | ~$310.00 | Save ~$240/inhaler |
| Generic fluticasone propionate | ~$50–$80 | Already low |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply for and provides Arnuity Ellipta at no medication cost if approved. But the process involves detailed applications, prescriber coordination, and ongoing renewal management. Our $69.95/month service covers full advocacy. Note: generic fluticasone propionate (Flovent equivalent) is widely available at $50–$80 per inhaler — for many patients, the generic ICS path is the better choice.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Arnuity Ellipta:
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Arnuity Ellipta assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Arnuity Ellipta (fluticasone furoate) is a once-daily inhaled corticosteroid (ICS) used as maintenance treatment of asthma in patients 5 years and older. It is delivered via the Ellipta dry-powder inhaler. Arnuity is a controller (preventer) medication, not a rescue inhaler — patients should still have a separate short-acting bronchodilator for acute symptoms.
How Arnuity Ellipta Works:
Asthma involves chronic airway inflammation that makes lungs hyper-responsive to triggers like exercise or allergens. Arnuity Ellipta delivers fluticasone furoate, a potent corticosteroid that reduces this underlying inflammation over time. Its long airway residence time allows for convenient once-daily dosing compared to other twice-daily options. Consistent use decreases overall symptoms and the frequent need for rescue medications.
Form and use:
This medication is administered as one inhalation once daily via the Ellipta dry-powder inhaler at the same time each day. It comes in three strengths—50 mcg, 100 mcg, and 200 mcg—prescribed based on the severity of the asthma. Each inhaler provides 30 doses, and patients must rinse their mouth after use to prevent oral thrush. It serves as a daily controller and is not intended for acute asthma attacks.
Generic availability:
As of 2026, there is no FDA-approved generic version specifically for Arnuity Ellipta in the U.S. However, several other inhaled corticosteroids are available as generics or lower-cost alternatives, such as fluticasone propionate and budesonide. Choosing an alternative depends on factors like dosing convenience, inhaler technique, and personal tolerability. Your prescriber can help determine which option fits your clinical needs.
Warnings:
Arnuity Ellipta should not be used as a rescue inhaler for sudden symptoms. Potential risks include localized oral thrush infections, reduced bone density, and slowed growth velocity in children. Long-term use may also lead to ocular issues like glaucoma or cataracts, as well as adrenal suppression at higher doses. Contact a prescriber if you experience vision changes, eye pain, or persistent oral discomfort.
The average retail price runs approximately $300–$420 per Ellipta inhaler. Generic fluticasone propionate is widely available at $50–$80 per inhaler. Through AffordMyPrescriptions, qualifying patients receive Arnuity at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Both are inhaled corticosteroids from the fluticasone family, but they use different fluticasone forms (furoate in Arnuity, propionate in Flovent). Arnuity is dosed once daily; Flovent is dosed twice daily. Generic fluticasone propionate (Flovent equivalent) is now widely available at low cost. Whether the once-daily convenience of Arnuity is worth the higher cost depends on your situation.
No. Arnuity Ellipta is a controller (maintenance) inhaler — it is taken once daily on a regular schedule to reduce airway inflammation over time. It is not for the acute treatment of asthma symptoms. You should still have a separate short-acting rescue inhaler (typically albuterol) for sudden symptoms.
Yes. Generic fluticasone propionate (Flovent equivalent) is widely available at $50–$80 per inhaler — much cheaper than brand Arnuity. Other inhaled corticosteroids with generic options include budesonide (Pulmicort, generic). We mention this directly because for many patients, a generic ICS at low cost is the better path. Discuss with your prescriber whether a switch makes sense.
Open the cover until you hear a click. Breathe out fully (away from the inhaler). Place the mouthpiece in your mouth, close your lips around it, and inhale long and steadily. Hold your breath for 3–4 seconds. Close the cover. Rinse your mouth with water. The dose counter on the inhaler shows how many doses are left.
If your initial application is denied, we explore alternatives — switching to generic fluticasone propionate or another generic ICS, the manufacturer’s copay savings program if you have commercial insurance, independent foundations such as the Asthma and Allergy Foundation of America, American Lung Association, PAN Foundation, or HealthWell Foundation, or asking your prescriber whether a different ICS would be appropriate. If we cannot find a path, you will not be charged our service fee.
If you are struggling with the high cost of Arnuity Ellipta, our team may be able to help you access assistance programs — or guide you to a much cheaper generic ICS alternative if it is the better fit. Check your eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.